Clinical evidence SUSTAIN 5: semaglutide added to basal insulin The SUSTAIN 5 trial studied 397 people with type 2 diabetes already on basal insulin, with or without metformin
Both medications work most effectively when combined with lifestyle modifications including caloric restriction and regular physical activity
He is often woken in the night by feeling sick, and suffers from regular nausea, violent belching, stomach aches and diarrhoea
Among tirzepatide users, the most commonly reported symptoms were similar: nausea (28.6%), fatigue (14.7%), vomiting (11.1%), constipation (12.9%), and diarrhea (12.5%)
Your wellness journey is personal
Semaglutide helps to control blood sugar by improving insulin response and reducing blood glucose levels